Cargando…
Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
AIM: To investigate the association between serum human epidermal growth factor receptor 2 (HER2) extracellular domain (ECD) and tissue HER2 status, and the prognostic value of serum HER2 ECD in patients with gastric cancer. METHODS: A total of 239 patients with gastric cancer were enrolled from Dec...
Autores principales: | Shi, Hong-Zhi, Wang, Yu-Ning, Huang, Xiao-Hui, Zhang, Ke-Cheng, Xi, Hong-Qing, Cui, Jian-Xin, Liu, Guo-Xiao, Liang, Wen-Tao, Wei, Bo, Chen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352924/ https://www.ncbi.nlm.nih.gov/pubmed/28348489 http://dx.doi.org/10.3748/wjg.v23.i10.1836 |
Ejemplares similares
-
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
por: Kaito, Akio, et al.
Publicado: (2019) -
Establishment and validation of a nomogram to predict the risk of ovarian metastasis in gastric cancer: Based on a large cohort
por: Li, Shao-Qing, et al.
Publicado: (2020) -
Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
por: Wang, Xin-Yu, et al.
Publicado: (2019) -
Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Kecheng, et al.
Publicado: (2015) -
Serum HER 2 Extracellular Domain Level Is Correlated with Tissue HER 2 Status in Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma
por: Dai, Shu-Qin, et al.
Publicado: (2013)